Aligos Therapeutics, Inc.
ALGS
$5.45
-$0.38-6.52%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -58.04% | 6.38% | 4.07% | 8.91% | 7.85% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -3.31% | 16.28% | 47.84% | -9.94% | -30.29% |
Total Current Assets | -55.95% | 6.94% | 5.65% | 7.89% | 5.65% |
|
|||||
Total Current Assets | -55.95% | 6.94% | 5.65% | 7.89% | 5.65% |
Net Property, Plant & Equipment | -25.38% | -24.72% | -23.56% | -21.10% | -21.54% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.32% | 1.93% | 1.12% | -1.11% | -1.42% |
Total Assets | -53.74% | 3.00% | 2.53% | 5.06% | 3.30% |
|
|||||
Total Accounts Payable | 2.15% | -6.83% | 110.40% | 0.71% | -46.87% |
Total Accrued Expenses | -7.63% | 14.92% | -12.55% | -20.14% | 5.01% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 6.76% | 4.45% | 3.65% | 3.97% | 3.05% |
Total Finance Division Other Current Liabilities | -88.46% | -83.42% | -80.93% | -89.74% | -85.80% |
Total Other Current Liabilities | -88.46% | -83.42% | -80.93% | -89.74% | -85.80% |
Total Current Liabilities | -9.07% | -6.73% | -13.45% | -32.76% | -27.84% |
|
|||||
Total Current Liabilities | -9.07% | -6.73% | -13.45% | -32.76% | -27.84% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -37.75% | -32.69% | -29.37% | -18.21% | -16.24% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 161.97% | 25,206.52% | 12,304.30% | 45,077.42% | 11,763.52% |
Total Liabilities | 66.65% | 23.52% | 13.94% | 84.13% | 38.92% |
|
|||||
Common Stock & APIC | 1.77% | 14.06% | 14.38% | 14.74% | 15.06% |
Retained Earnings | -26.95% | -16.77% | -17.18% | -23.59% | -21.97% |
Treasury Stock & Other | -17.25% | 16.10% | -0.60% | -4.61% | 35.91% |
Total Common Equity | -131.47% | -8.62% | -3.46% | -29.44% | -11.38% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -131.47% | -8.62% | -3.46% | -29.44% | -11.38% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -131.47% | -8.62% | -3.46% | -29.44% | -11.38% |
|